Allspring Global Investments Holdings, LLC Inhibrx, Inc. Transaction History

Allspring Global Investments Holdings, LLC

  • $62.1 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
SELL
$20.18 - $33.33 $100 - $166
-5 Reduced 2.45%
199 $0
Q3 2022

Oct 26, 2022
SELL
$11.58 - $24.73 $2,188 - $4,673
-189 Reduced 48.09%
204 $3,000
Q2 2022

Jul 25, 2022
SELL
$8.52 - $25.26 $32,077 - $95,103
-3,765 Reduced 90.55%
393 $4,000
Q1 2022

May 02, 2022
BUY
$19.89 - $43.18 $12,152 - $26,382
611 Added 17.23%
4,158 $92,000
Q4 2021

Jan 28, 2022
BUY
$26.75 - $46.02 $94,882 - $163,232
3,547 New
3,547 $154,000

Others Institutions Holding INBX

# of Institutions
2
Shares Held
25.3K
Call Options Held
0
Put Options Held
0
View Full List

About Inhibrx, Inc.

INBX Quotes by TradingView
  • Ticker INBX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,057,700
  • Market Cap $617M
  • Description
  • Inhibrx, Inc., a clinical-stage biotechnology company, focuses on developing a pipeline of novel biologic therapeutic candidates. The company's therapeutic candidates include INBRX-109, a tetravalent agonist of death receptor 5, which is in Phase 2 clinical trials to treat cancers, such as chondrosarcoma, mesothelioma, and pancreatic adenocarcin...
More about INBX
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email